
Ikvapir-TZ 4.5 Injection
Marketer
Ikvans Pharma
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Ikvapir-TZ 4.5 Injection
The dual-antibiotic formulation, Ikvapir-TZ 4.5 Injection, combats bacterial infections by eliminating microorganisms. Administered only by medical professionals, its dosage and frequency are determined by a physician based on the patient's condition. Strict adherence to the prescribed regimen is essential. Commonly reported side effects encompass nausea, vomiting, diarrhea, and skin rashes, along with potential injection site reactions such as pain, swelling, or redness. Persistent or worsening side effects warrant immediate medical consultation. Prior to treatment, disclose any antibiotic allergies or pre-existing kidney or liver issues to your doctor; adjustments to the dosage or alternative medication may be necessary. Under medical guidance, this injection is generally considered safe for use during pregnancy and lactation.
Uses of Ikvapir-TZ 4.5 Injection
Infections caused by bacteria
Major Benefits of Ikvapir-TZ 4.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ikvapir-TZ 4.5 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Ikvapir-TZ 4.5 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Ikvapir-TZ 4.5 Injection works:
Ikvapir-TZ 4.5 Injection unites Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby boosting Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Ikvapir-TZ 4.5 Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Ikvapir-TZ 4.5 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Ikvapir-TZ 4.5 poses no known breastfeeding risks. Research in humans indicates minimal drug transfer to breast milk, presenting no apparent danger to infants.
DrivingCONSULT YOUR DOCTOR
Ikvapir-TZ 4.5 Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Administering Ikvapir-TZ 4.5 Injection to individuals with impaired renal function requires careful consideration. Dosage modification for Ikvapir-TZ 4.5 Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Ikvapir-TZ 4.5 Injection in patients with hepatic impairment is likely safe. Available evidence indicates dose modification may be unnecessary for this population. However, physician consultation is recommended.
What if you forget to take Ikvapir-TZ 4.5 Injection :
Should you inadvertently skip a dose of Ikvapir-TZ 4.5 Injection, seek medical advice.
Facts to Know About Ikvapir-TZ 4.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
